chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Swelling
Clinical narrative: Fatigue; some swelling between clavicle and neck for first couple days; Intermittent pain which was just uncomfortable/just sore mostly in upper body; Little bit of sore arm; Really bad shoulder pain and joint pain; little bit nausea; little bit chills; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (some swelling between clavicle and neck for first couple days), PAIN (Intermittent pain which was just uncomfortable/just sore mostly in upper body), PAIN IN EXTREMITY (Little bit of sore arm), ARTHRALGIA (Really bad shoulder pain and joint pain) and NAUSEA (little bit nausea) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Breast cancer. Concurrent medical conditions included Anxiety.    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced SWELLING (some swelling between clavicle and neck for first couple days), PAIN (Intermittent pain which was just uncomfortable/just sore mostly in upper body), PAIN IN EXTREMITY (Little bit of sore arm), ARTHRALGIA (Really bad shoulder pain and joint pain), NAUSEA (little bit nausea) and CHILLS (little bit chills). On an unknown date, the patient experienced FATIGUE (Fatigue). At the time of the report, SWELLING (some swelling between clavicle and neck for first couple days), PAIN (Intermittent pain which was just uncomfortable/just sore mostly in upper body), PAIN IN EXTREMITY (Little bit of sore arm), ARTHRALGIA (Really bad shoulder pain and joint pain), NAUSEA (little bit nausea), CHILLS (little bit chills) and FATIGUE (Fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported No treatment drugs were reported
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Pain in extremity, SARS-CoV-2 test, Taste disorder
Clinical narrative: sore arm; funny taste in mouth; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and TASTE DISORDER (funny taste in mouth) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 002A21A) for COVID-19 vaccination.     The patient's past medical history included Resistant hypertension, Vertigo (unbalance, vertigo, double vision, headaches.), Cardiac catheterisation in 2014, Kidney atrophy, Arterial stenosis, Autoimmune disorder (Mixed connective tissue disease), Hashimoto's disease and Lichen sclerosis atrophicus. Previously administered products included for an unreported indication: PNEUMO 23 (PPS23). Concurrent medical conditions included Allergy to antibiotic (sulfa, ), Allergy to antibiotic (chlorthalidone), Contrast media allergy and Reaction to vaccine preservatives (Reaction to PEG). Concomitant products included AMLODIPINE BESILATE (NORVASC) for Angina syndrome, METOPROLOL for Arrhythmia, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for Coronary artery disease, LOSARTAN POTASSIUM (COZAAR) for Hypertension, APIXABAN (ELIQUIS) for an unknown indication.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm) and TASTE DISORDER (funny taste in mouth). At the time of the report, PAIN IN EXTREMITY (sore arm) and TASTE DISORDER (funny taste in mouth) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: high (High) 168 over ?. On an unknown date, SARS-CoV-2 test: negative (Negative) Negative.         No treatment medications were reported   This case was linked to MOD-2021-073821 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: The patient was given the second dose 2 weeks after the first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (The patient was given the second dose 2 weeks after the first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (The patient was given the second dose 2 weeks after the first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (The patient was given the second dose 2 weeks after the first dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant products were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, Sneezing
Clinical narrative: runny nose; sneezing; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (runny nose) and SNEEZING (sneezing) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, the patient experienced RHINORRHOEA (runny nose) and SNEEZING (sneezing). At the time of the report, RHINORRHOEA (runny nose) and SNEEZING (sneezing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant products were reported. No treatment information was provided.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Pyrexia
Clinical narrative: tiredness; fever; nausea; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tiredness), PYREXIA (fever) and NAUSEA (nausea) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 040821A) for COVID-19 vaccination.     The patient's past medical history included Hashimoto's thyroiditis on 09-May-2003. Concurrent medical conditions included Allergy to antibiotic (tetracycline), Penicillin allergy and Cosmetic allergy (allergic to some skin care products.). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroiditis, VITAMIN B [VITAMIN B NOS], ASCORBIC ACID (VITAMIN C ACID), VITAMIN D NOS, PROBIOTICS NOS and MAGNESIUM for an unknown indication.   On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (tiredness), PYREXIA (fever) and NAUSEA (nausea). At the time of the report, FATIGUE (tiredness), PYREXIA (fever) and NAUSEA (nausea) outcome was unknown.            treatment to the events not provided. Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-071125 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: second dose as day 22; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose as day 22) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose as day 22). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose as day 22) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   patient took second dose on 12-may-2021 patient want to ask is the second dose is valid dose. no concomitant medications are reported.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Arthralgia, Dehydration, Diarrhoea, Ear infection
Clinical narrative: Decreased mobility; Neck pain; pain in face; Ear pain; sinus pressure; pain all over the body; Fluid in middle ear; weakness of limbs; Ear infection; Anxiety; Dehydration; diarrhea; Numbness of limbs; sensation of pressure in eye; Leg pain; Knee pain; Myalgia; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Leg pain), ARTHRALGIA (Knee pain), MOBILITY DECREASED (Decreased mobility), NECK PAIN (Neck pain) and FACIAL PAIN (pain in face) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, the patient experienced PAIN IN EXTREMITY (Leg pain), ARTHRALGIA (Knee pain) and MYALGIA (Myalgia). On 17-Apr-2021, the patient experienced OCULAR DISCOMFORT (sensation of pressure in eye), ANXIETY (Anxiety), DEHYDRATION (Dehydration), DIARRHOEA (diarrhea) and HYPOAESTHESIA (Numbness of limbs). On 19-Apr-2021, the patient experienced MUSCULAR WEAKNESS (weakness of limbs) and EAR INFECTION (Ear infection). On an unknown date, the patient experienced MOBILITY DECREASED (Decreased mobility), NECK PAIN (Neck pain), FACIAL PAIN (pain in face), EAR PAIN (Ear pain), PARANASAL SINUS DISCOMFORT (sinus pressure), PAIN (pain all over the body) and MIDDLE EAR EFFUSION (Fluid in middle ear). The patient was treated with AMOXICILLIN TRIHYDRATE, CLAVULANATE POTASSIUM (AUGMENTIN BD) at an unspecified dose and frequency; PREDNISONE for Ear pain, at a dose of 1 dosage form and DOXYCYCLINE for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Leg pain), ARTHRALGIA (Knee pain), MOBILITY DECREASED (Decreased mobility), NECK PAIN (Neck pain), FACIAL PAIN (pain in face), EAR PAIN (Ear pain), PARANASAL SINUS DISCOMFORT (sinus pressure), OCULAR DISCOMFORT (sensation of pressure in eye), PAIN (pain all over the body), ANXIETY (Anxiety), DEHYDRATION (Dehydration), DIARRHOEA (diarrhea), HYPOAESTHESIA (Numbness of limbs), MUSCULAR WEAKNESS (weakness of limbs), EAR INFECTION (Ear infection), MIDDLE EAR EFFUSION (Fluid in middle ear) and MYALGIA (Myalgia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Facial pain, Hypoaesthesia, Middle ear effusion, Mobility decreased
Clinical narrative: Decreased mobility; Neck pain; pain in face; Ear pain; sinus pressure; pain all over the body; Fluid in middle ear; weakness of limbs; Ear infection; Anxiety; Dehydration; diarrhea; Numbness of limbs; sensation of pressure in eye; Leg pain; Knee pain; Myalgia; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Leg pain), ARTHRALGIA (Knee pain), MOBILITY DECREASED (Decreased mobility), NECK PAIN (Neck pain) and FACIAL PAIN (pain in face) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, the patient experienced PAIN IN EXTREMITY (Leg pain), ARTHRALGIA (Knee pain) and MYALGIA (Myalgia). On 17-Apr-2021, the patient experienced OCULAR DISCOMFORT (sensation of pressure in eye), ANXIETY (Anxiety), DEHYDRATION (Dehydration), DIARRHOEA (diarrhea) and HYPOAESTHESIA (Numbness of limbs). On 19-Apr-2021, the patient experienced MUSCULAR WEAKNESS (weakness of limbs) and EAR INFECTION (Ear infection). On an unknown date, the patient experienced MOBILITY DECREASED (Decreased mobility), NECK PAIN (Neck pain), FACIAL PAIN (pain in face), EAR PAIN (Ear pain), PARANASAL SINUS DISCOMFORT (sinus pressure), PAIN (pain all over the body) and MIDDLE EAR EFFUSION (Fluid in middle ear). The patient was treated with AMOXICILLIN TRIHYDRATE, CLAVULANATE POTASSIUM (AUGMENTIN BD) at an unspecified dose and frequency; PREDNISONE for Ear pain, at a dose of 1 dosage form and DOXYCYCLINE for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Leg pain), ARTHRALGIA (Knee pain), MOBILITY DECREASED (Decreased mobility), NECK PAIN (Neck pain), FACIAL PAIN (pain in face), EAR PAIN (Ear pain), PARANASAL SINUS DISCOMFORT (sinus pressure), OCULAR DISCOMFORT (sensation of pressure in eye), PAIN (pain all over the body), ANXIETY (Anxiety), DEHYDRATION (Dehydration), DIARRHOEA (diarrhea), HYPOAESTHESIA (Numbness of limbs), MUSCULAR WEAKNESS (weakness of limbs), EAR INFECTION (Ear infection), MIDDLE EAR EFFUSION (Fluid in middle ear) and MYALGIA (Myalgia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Myalgia, Neck pain, Ocular discomfort, Pain
Clinical narrative: Decreased mobility; Neck pain; pain in face; Ear pain; sinus pressure; pain all over the body; Fluid in middle ear; weakness of limbs; Ear infection; Anxiety; Dehydration; diarrhea; Numbness of limbs; sensation of pressure in eye; Leg pain; Knee pain; Myalgia; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Leg pain), ARTHRALGIA (Knee pain), MOBILITY DECREASED (Decreased mobility), NECK PAIN (Neck pain) and FACIAL PAIN (pain in face) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, the patient experienced PAIN IN EXTREMITY (Leg pain), ARTHRALGIA (Knee pain) and MYALGIA (Myalgia). On 17-Apr-2021, the patient experienced OCULAR DISCOMFORT (sensation of pressure in eye), ANXIETY (Anxiety), DEHYDRATION (Dehydration), DIARRHOEA (diarrhea) and HYPOAESTHESIA (Numbness of limbs). On 19-Apr-2021, the patient experienced MUSCULAR WEAKNESS (weakness of limbs) and EAR INFECTION (Ear infection). On an unknown date, the patient experienced MOBILITY DECREASED (Decreased mobility), NECK PAIN (Neck pain), FACIAL PAIN (pain in face), EAR PAIN (Ear pain), PARANASAL SINUS DISCOMFORT (sinus pressure), PAIN (pain all over the body) and MIDDLE EAR EFFUSION (Fluid in middle ear). The patient was treated with AMOXICILLIN TRIHYDRATE, CLAVULANATE POTASSIUM (AUGMENTIN BD) at an unspecified dose and frequency; PREDNISONE for Ear pain, at a dose of 1 dosage form and DOXYCYCLINE for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Leg pain), ARTHRALGIA (Knee pain), MOBILITY DECREASED (Decreased mobility), NECK PAIN (Neck pain), FACIAL PAIN (pain in face), EAR PAIN (Ear pain), PARANASAL SINUS DISCOMFORT (sinus pressure), OCULAR DISCOMFORT (sensation of pressure in eye), PAIN (pain all over the body), ANXIETY (Anxiety), DEHYDRATION (Dehydration), DIARRHOEA (diarrhea), HYPOAESTHESIA (Numbness of limbs), MUSCULAR WEAKNESS (weakness of limbs), EAR INFECTION (Ear infection), MIDDLE EAR EFFUSION (Fluid in middle ear) and MYALGIA (Myalgia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Paranasal sinus discomfort
Clinical narrative: Decreased mobility; Neck pain; pain in face; Ear pain; sinus pressure; pain all over the body; Fluid in middle ear; weakness of limbs; Ear infection; Anxiety; Dehydration; diarrhea; Numbness of limbs; sensation of pressure in eye; Leg pain; Knee pain; Myalgia; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Leg pain), ARTHRALGIA (Knee pain), MOBILITY DECREASED (Decreased mobility), NECK PAIN (Neck pain) and FACIAL PAIN (pain in face) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, the patient experienced PAIN IN EXTREMITY (Leg pain), ARTHRALGIA (Knee pain) and MYALGIA (Myalgia). On 17-Apr-2021, the patient experienced OCULAR DISCOMFORT (sensation of pressure in eye), ANXIETY (Anxiety), DEHYDRATION (Dehydration), DIARRHOEA (diarrhea) and HYPOAESTHESIA (Numbness of limbs). On 19-Apr-2021, the patient experienced MUSCULAR WEAKNESS (weakness of limbs) and EAR INFECTION (Ear infection). On an unknown date, the patient experienced MOBILITY DECREASED (Decreased mobility), NECK PAIN (Neck pain), FACIAL PAIN (pain in face), EAR PAIN (Ear pain), PARANASAL SINUS DISCOMFORT (sinus pressure), PAIN (pain all over the body) and MIDDLE EAR EFFUSION (Fluid in middle ear). The patient was treated with AMOXICILLIN TRIHYDRATE, CLAVULANATE POTASSIUM (AUGMENTIN BD) at an unspecified dose and frequency; PREDNISONE for Ear pain, at a dose of 1 dosage form and DOXYCYCLINE for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Leg pain), ARTHRALGIA (Knee pain), MOBILITY DECREASED (Decreased mobility), NECK PAIN (Neck pain), FACIAL PAIN (pain in face), EAR PAIN (Ear pain), PARANASAL SINUS DISCOMFORT (sinus pressure), OCULAR DISCOMFORT (sensation of pressure in eye), PAIN (pain all over the body), ANXIETY (Anxiety), DEHYDRATION (Dehydration), DIARRHOEA (diarrhea), HYPOAESTHESIA (Numbness of limbs), MUSCULAR WEAKNESS (weakness of limbs), EAR INFECTION (Ear infection), MIDDLE EAR EFFUSION (Fluid in middle ear) and MYALGIA (Myalgia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Lymphadenopathy
Clinical narrative: Lymph node size of a grape on left collar bone; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), HEADACHE (Headache) and LYMPHADENOPATHY (Lymph node size of a grape on left collar bone) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] and MECLIZINE [MECLOZINE] for an unknown indication.    On 01-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, the patient experienced CHILLS (Chills) and HEADACHE (Headache). On 05-May-2021, the patient experienced LYMPHADENOPATHY (Lymph node size of a grape on left collar bone). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 03-May-2021, CHILLS (Chills) and HEADACHE (Headache) had resolved. On 13-May-2021, LYMPHADENOPATHY (Lymph node size of a grape on left collar bone) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant medications included Tylenol.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Dysgraphia, Lethargy, Musculoskeletal stiffness, Vaccination site pain
Clinical narrative: I started getting stiffness in the right wrist and fingers; Effecting his writing; Bilateral wrist and finger pain mostly in his joints; Feeling lethargic; Pain at injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of LETHARGY (Feeling lethargic), MUSCULOSKELETAL STIFFNESS (I started getting stiffness in the right wrist and fingers), DYSGRAPHIA (Effecting his writing), VACCINATION SITE PAIN (Pain at injection site) and ARTHRALGIA (Bilateral wrist and finger pain mostly in his joints) in an 89-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 026A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced LETHARGY (Feeling lethargic) and VACCINATION SITE PAIN (Pain at injection site). On 26-Feb-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (I started getting stiffness in the right wrist and fingers), DYSGRAPHIA (Effecting his writing) and ARTHRALGIA (Bilateral wrist and finger pain mostly in his joints). The patient was treated with DICLOFENAC SODIUM (VOLTAREN [DICLOFENAC SODIUM]) at an unspecified dose and frequency. On 22-Feb-2021, LETHARGY (Feeling lethargic) and VACCINATION SITE PAIN (Pain at injection site) had resolved. At the time of the report, MUSCULOSKELETAL STIFFNESS (I started getting stiffness in the right wrist and fingers) outcome was unknown and DYSGRAPHIA (Effecting his writing) and ARTHRALGIA (Bilateral wrist and finger pain mostly in his joints) had not resolved.            Action taken with mRNA-1273 in response to the events was  not applicable.  No concomitant products were reported.  Other treatment information provided included moist heat, a heating pad.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Follow up received on 15-JUN-2021. Patient contact information has been updated.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Headache, Nausea, Neck pain, Pyrexia
Clinical narrative: Neck pain; Nausea; Headache; Temperature 97, temperature 98.5; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Neck pain), NAUSEA (Nausea), PYREXIA (Temperature 97, temperature 98.5) and HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 12-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-May-2021, the patient experienced PYREXIA (Temperature 97, temperature 98.5). On 13-May-2021, the patient experienced NECK PAIN (Neck pain), NAUSEA (Nausea) and HEADACHE (Headache). At the time of the report, NECK PAIN (Neck pain), NAUSEA (Nausea), PYREXIA (Temperature 97, temperature 98.5) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 98.5 (High) 98.5 F at 9.30 am 97 F at night..         Patient wants to know when to take Acetaminophen. Concomitant medications information was not reported. Treatment medications were not provided by the reporter.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Fatigue, Muscular weakness
Clinical narrative: COVID-19; Coughing; Muscle weakness; Fever; Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19), COUGH (Coughing), MUSCULAR WEAKNESS (Muscle weakness), PYREXIA (Fever) and CHILLS (Chills) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 25-Apr-2021. Concomitant products included FLUVOXAMINE and RISPERIDONE (RISPERDAL) for an unknown indication.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Apr-2021, the patient experienced COVID-19 (COVID-19), COUGH (Coughing), MUSCULAR WEAKNESS (Muscle weakness), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Fatigue). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) ongoing since an unknown date at an unspecified dose and frequency. On 08-May-2021, COVID-19 (COVID-19), COUGH (Coughing), MUSCULAR WEAKNESS (Muscle weakness), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: unknown (Positive) COVID Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: COVID-19; Coughing; Muscle weakness; Fever; Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19), COUGH (Coughing), MUSCULAR WEAKNESS (Muscle weakness), PYREXIA (Fever) and CHILLS (Chills) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 25-Apr-2021. Concomitant products included FLUVOXAMINE and RISPERIDONE (RISPERDAL) for an unknown indication.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Apr-2021, the patient experienced COVID-19 (COVID-19), COUGH (Coughing), MUSCULAR WEAKNESS (Muscle weakness), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Fatigue). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) ongoing since an unknown date at an unspecified dose and frequency. On 08-May-2021, COVID-19 (COVID-19), COUGH (Coughing), MUSCULAR WEAKNESS (Muscle weakness), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: unknown (Positive) COVID Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Lacrimation increased, Myalgia
Clinical narrative: Watery secretion from that eye; Left eye red; Fatigue; Headache; muscle pain; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of LACRIMATION INCREASED (Watery secretion from that eye), OCULAR HYPERAEMIA (Left eye red), FATIGUE (Fatigue), HEADACHE (Headache) and MYALGIA (muscle pain) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided.  Concomitant products included VITAMINS NOS for an unknown indication.   On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-May-2021, the patient experienced LACRIMATION INCREASED (Watery secretion from that eye), OCULAR HYPERAEMIA (Left eye red), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (muscle pain) and ARTHRALGIA (Joint pain). At the time of the report, LACRIMATION INCREASED (Watery secretion from that eye), OCULAR HYPERAEMIA (Left eye red), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (muscle pain) and ARTHRALGIA (Joint pain) had resolved.            Action taken with mRNA-1273 in response to the event was not applicable.  Concomitant medications taken were antioxidants( blueberry and Lutein).  Treatment medications were not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Follow up received on 14-JUN-2021. Patient 2nd dose and event outcome was updated.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Ocular hyperaemia
Clinical narrative: Watery secretion from that eye; Left eye red; Fatigue; Headache; muscle pain; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of LACRIMATION INCREASED (Watery secretion from that eye), OCULAR HYPERAEMIA (Left eye red), FATIGUE (Fatigue), HEADACHE (Headache) and MYALGIA (muscle pain) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided.  Concomitant products included VITAMINS NOS for an unknown indication.   On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-May-2021, the patient experienced LACRIMATION INCREASED (Watery secretion from that eye), OCULAR HYPERAEMIA (Left eye red), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (muscle pain) and ARTHRALGIA (Joint pain). At the time of the report, LACRIMATION INCREASED (Watery secretion from that eye), OCULAR HYPERAEMIA (Left eye red), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (muscle pain) and ARTHRALGIA (Joint pain) had resolved.            Action taken with mRNA-1273 in response to the event was not applicable.  Concomitant medications taken were antioxidants( blueberry and Lutein).  Treatment medications were not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Follow up received on 14-JUN-2021. Patient 2nd dose and event outcome was updated.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Really bad headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Really bad headache) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033b21a) for COVID-19 vaccination.     No Medical History information was reported.    On 13-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-May-2021, the patient experienced HEADACHE (Really bad headache). At the time of the report, HEADACHE (Really bad headache) outcome was unknown.            No concomitant medications were reported. Treatment medications were not provided by the reporter.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Muscle twitching, Paraesthesia
Clinical narrative: tingling sensation on all of the right side of my body; pinky finger got twitched; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling sensation on all of the right side of my body) and MUSCLE TWITCHING (pinky finger got twitched) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced PARAESTHESIA (tingling sensation on all of the right side of my body) and MUSCLE TWITCHING (pinky finger got twitched). At the time of the report, PARAESTHESIA (tingling sensation on all of the right side of my body) and MUSCLE TWITCHING (pinky finger got twitched) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medications were reported. Treatment medications were not provided by the reporter.    This case was linked to MOD-2021-127292 (Patient Link).
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Somnolence
Clinical narrative: Fall asleep; Tired; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Fall asleep) and FATIGUE (Tired) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-May-2021, the patient experienced SOMNOLENCE (Fall asleep) and FATIGUE (Tired). At the time of the report, SOMNOLENCE (Fall asleep) and FATIGUE (Tired) outcome was unknown.            Treatment drugs were not reported concomitant drugs
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Inappropriate schedule of product administration, Pyrexia, Vaccination site erythema
Clinical narrative: Low grade Fever; Inappropriate schedule of vaccine administration; Injection site swollen; Injection site pain/tender; High Fever; Injection site red; Headaches; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE SWELLING (Injection site swollen), VACCINATION SITE PAIN (Injection site pain/tender), PYREXIA (High Fever), VACCINATION SITE ERYTHEMA (Injection site red) and HEADACHE (Headaches) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Migraine. Concomitant products included LEVOTHYROXINE, ESCITALOPRAM OXALATE (LEXAPRO) and TRAZODONE for an unknown indication.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Apr-2021, the patient experienced VACCINATION SITE SWELLING (Injection site swollen), VACCINATION SITE PAIN (Injection site pain/tender), PYREXIA (High Fever), VACCINATION SITE ERYTHEMA (Injection site red), HEADACHE (Headaches) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administration). On 30-Apr-2021, the patient experienced PYREXIA (Low grade Fever). The patient was treated with SUMATRIPTAN ongoing since an unknown date for Migraine, at a dose of 1 dosage form; BUTALBITAL, CAFFEINE, PARACETAMOL (FIORICET) ongoing since an unknown date for Migraine, at a dose of 1 dosage form and ACETAMINOPHEN at a dose of 1 dosage form. On 27-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administration) had resolved. On 29-Apr-2021, PYREXIA (High Fever) had resolved. On 04-May-2021, VACCINATION SITE SWELLING (Injection site swollen), VACCINATION SITE PAIN (Injection site pain/tender) and VACCINATION SITE ERYTHEMA (Injection site red) had resolved. On 06-May-2021, HEADACHE (Headaches) and PYREXIA (Low grade Fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Apr-2021, Body temperature: 103.8 (High) High fever of 103.8.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Other concomitant medications included Sumatriptan and Fioricet.    This case was linked to MOD21-090108 (E2B Linked Report).; Sender's Comments:  MOD21-090108:
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: Low grade Fever; Inappropriate schedule of vaccine administration; Injection site swollen; Injection site pain/tender; High Fever; Injection site red; Headaches; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE SWELLING (Injection site swollen), VACCINATION SITE PAIN (Injection site pain/tender), PYREXIA (High Fever), VACCINATION SITE ERYTHEMA (Injection site red) and HEADACHE (Headaches) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Migraine. Concomitant products included LEVOTHYROXINE, ESCITALOPRAM OXALATE (LEXAPRO) and TRAZODONE for an unknown indication.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Apr-2021, the patient experienced VACCINATION SITE SWELLING (Injection site swollen), VACCINATION SITE PAIN (Injection site pain/tender), PYREXIA (High Fever), VACCINATION SITE ERYTHEMA (Injection site red), HEADACHE (Headaches) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administration). On 30-Apr-2021, the patient experienced PYREXIA (Low grade Fever). The patient was treated with SUMATRIPTAN ongoing since an unknown date for Migraine, at a dose of 1 dosage form; BUTALBITAL, CAFFEINE, PARACETAMOL (FIORICET) ongoing since an unknown date for Migraine, at a dose of 1 dosage form and ACETAMINOPHEN at a dose of 1 dosage form. On 27-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administration) had resolved. On 29-Apr-2021, PYREXIA (High Fever) had resolved. On 04-May-2021, VACCINATION SITE SWELLING (Injection site swollen), VACCINATION SITE PAIN (Injection site pain/tender) and VACCINATION SITE ERYTHEMA (Injection site red) had resolved. On 06-May-2021, HEADACHE (Headaches) and PYREXIA (Low grade Fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Apr-2021, Body temperature: 103.8 (High) High fever of 103.8.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Other concomitant medications included Sumatriptan and Fioricet.    This case was linked to MOD21-090108 (E2B Linked Report).; Sender's Comments:  MOD21-090108:
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Injection site mass, Pain in extremity, Pruritus
Clinical narrative: Itching; Loss of apatite; Weakness; Big bump by injection site; Injection site was red; Fever; Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Loss of apatite), PRURITUS (Itching), PAIN IN EXTREMITY (Sore Arm), ASTHENIA (Weakness) and INJECTION SITE MASS (Big bump by injection site) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001C21A and 025B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (Sore Arm). On 06-May-2021, the patient experienced DECREASED APPETITE (Loss of apatite), ASTHENIA (Weakness), INJECTION SITE MASS (Big bump by injection site), VACCINATION SITE ERYTHEMA (Injection site was red) and PYREXIA (Fever). On 12-May-2021, the patient experienced PRURITUS (Itching). The patient was treated with IBUPROFEN at a dose of 1 dosage form. On 07-May-2021, PAIN IN EXTREMITY (Sore Arm) had resolved. On 08-May-2021, DECREASED APPETITE (Loss of apatite), ASTHENIA (Weakness), INJECTION SITE MASS (Big bump by injection site), VACCINATION SITE ERYTHEMA (Injection site was red) and PYREXIA (Fever) had resolved. On 13-May-2021, PRURITUS (Itching) had resolved.            Concomitant product information was not provided.    This case was linked to MOD21-089871, US-MODERNATX, INC.-MOD-2021-128222 (E2B Linked Report).; Sender's Comments:  MOD21-089871:crosslinked to husband's report US-MODERNATX, INC.-MOD-2021-128222:
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site erythema
Clinical narrative: Itching; Loss of apatite; Weakness; Big bump by injection site; Injection site was red; Fever; Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Loss of apatite), PRURITUS (Itching), PAIN IN EXTREMITY (Sore Arm), ASTHENIA (Weakness) and INJECTION SITE MASS (Big bump by injection site) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001C21A and 025B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (Sore Arm). On 06-May-2021, the patient experienced DECREASED APPETITE (Loss of apatite), ASTHENIA (Weakness), INJECTION SITE MASS (Big bump by injection site), VACCINATION SITE ERYTHEMA (Injection site was red) and PYREXIA (Fever). On 12-May-2021, the patient experienced PRURITUS (Itching). The patient was treated with IBUPROFEN at a dose of 1 dosage form. On 07-May-2021, PAIN IN EXTREMITY (Sore Arm) had resolved. On 08-May-2021, DECREASED APPETITE (Loss of apatite), ASTHENIA (Weakness), INJECTION SITE MASS (Big bump by injection site), VACCINATION SITE ERYTHEMA (Injection site was red) and PYREXIA (Fever) had resolved. On 13-May-2021, PRURITUS (Itching) had resolved.            Concomitant product information was not provided.    This case was linked to MOD21-089871, US-MODERNATX, INC.-MOD-2021-128222 (E2B Linked Report).; Sender's Comments:  MOD21-089871:crosslinked to husband's report US-MODERNATX, INC.-MOD-2021-128222:
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Musculoskeletal stiffness, Myalgia
Clinical narrative: Injection site hard; Hand stiff; Hand swollen; Pain at the injection site; Body aches; Dizzy; Headache; Bitter vomit; Chills; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Hand stiff), PERIPHERAL SWELLING (Hand swollen), DIZZINESS (Dizzy), VACCINATION SITE INDURATION (Injection site hard) and HEADACHE (Headache) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cholesterol. Concomitant products included ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]) for an unknown indication.    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, the patient experienced DIZZINESS (Dizzy), HEADACHE (Headache), VOMITING (Bitter vomit), CHILLS (Chills) and MYALGIA (Body aches). On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (Hand stiff), PERIPHERAL SWELLING (Hand swollen), VACCINATION SITE INDURATION (Injection site hard) and VACCINATION SITE PAIN (Pain at the injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MUSCULOSKELETAL STIFFNESS (Hand stiff), PERIPHERAL SWELLING (Hand swollen), VACCINATION SITE INDURATION (Injection site hard), VACCINATION SITE PAIN (Pain at the injection site) and MYALGIA (Body aches) was resolving, DIZZINESS (Dizzy), HEADACHE (Headache) and CHILLS (Chills) had not resolved and VOMITING (Bitter vomit) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication include cholesterol medication.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Vaccination site induration, Vaccination site pain, Vomiting
Clinical narrative: Injection site hard; Hand stiff; Hand swollen; Pain at the injection site; Body aches; Dizzy; Headache; Bitter vomit; Chills; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Hand stiff), PERIPHERAL SWELLING (Hand swollen), DIZZINESS (Dizzy), VACCINATION SITE INDURATION (Injection site hard) and HEADACHE (Headache) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cholesterol. Concomitant products included ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]) for an unknown indication.    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, the patient experienced DIZZINESS (Dizzy), HEADACHE (Headache), VOMITING (Bitter vomit), CHILLS (Chills) and MYALGIA (Body aches). On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (Hand stiff), PERIPHERAL SWELLING (Hand swollen), VACCINATION SITE INDURATION (Injection site hard) and VACCINATION SITE PAIN (Pain at the injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MUSCULOSKELETAL STIFFNESS (Hand stiff), PERIPHERAL SWELLING (Hand swollen), VACCINATION SITE INDURATION (Injection site hard), VACCINATION SITE PAIN (Pain at the injection site) and MYALGIA (Body aches) was resolving, DIZZINESS (Dizzy), HEADACHE (Headache) and CHILLS (Chills) had not resolved and VOMITING (Bitter vomit) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication include cholesterol medication.